Department of Medicine
Andrea Wecker has not added Biography.
If you are Andrea Wecker and would like to personalize this page please email our Author Liaison for assistance.
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
The Journal of clinical investigation Mar, 2003 | Pubmed ID: 12618526
Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis.
Circulation Jul, 2004 | Pubmed ID: 15210598
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction.
The Journal of clinical investigation Feb, 2005 | Pubmed ID: 15690083
Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity.
Circulation Mar, 2005 | Pubmed ID: 15723985
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
Circulation May, 2005 | Pubmed ID: 15897348
Hyperhomocyst(e)inemia impairs angiogenesis in a murine model of limb ischemia.
Vascular medicine (London, England) Feb, 2005 | Pubmed ID: 15920995
Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
Circulation Jul, 2005 | Pubmed ID: 15983249
Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization.
The Journal of experimental medicine Jan, 2006 | Pubmed ID: 16401693
Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury.
Circulation research Mar, 2006 | Pubmed ID: 16484619
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI.
Nature clinical practice. Cardiovascular medicine Mar, 2006 | Pubmed ID: 16501618
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2006 | Pubmed ID: 16835303
Derivation and characterization of bone marrow-derived multipotent stem cells.
Experimental hematology Nov, 2006 | Pubmed ID: 17046582
Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction.
Circulation Nov, 2006 | Pubmed ID: 17088460
Bone marrow-derived stem cell therapy in ischemic heart disease.
Regenerative medicine May, 2006 | Pubmed ID: 17465787
Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart.
The Journal of experimental medicine Dec, 2007 | Pubmed ID: 18070934
Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.
Circulation Feb, 2009 | Pubmed ID: 19171856
Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice.
Circulation Mar, 2010 | Pubmed ID: 20176991
CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension.
Journal of hypertension Oct, 2013 | Pubmed ID: 23881298
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유